Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
10/2003
10/23/2003WO2003086393A1 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2002080150A3 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003CA2482775A1 Fredericamycin derivatives
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353673A1 Camptothecin derivatives
10/22/2003EP0892802B1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1450894A Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use
10/22/2003CN1125053C Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives in particular
10/21/2003US6635673 1-Aminomethyl-3,4-dimethyl-cyclopentyl acetic acid; epilepsy; neurodegenerative, neuropathological and gastrointestinal disorders; depression, anxiety, panic, pain
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084931A1 5h-benzo[4,5]cyclohepta[1,2-b]pyridine nmda/nr2b antagonists
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003US20030195358 Process for production of gabapentin intermediate
10/16/2003US20030195224 An immunomodulators, antitumor agents and induce cytokine biosynthesis, treating viral diseases
10/16/2003US20030195216 Octahydro-2H-pyrido[1,2-a] pyrazine compounds
10/16/2003US20030195204 Quinoline derivatives as NK3 antagonists
10/16/2003US20030195188 Pyridine and quinoline derivatives
10/16/2003US20030195187 For therapy of obesity or type II diabetes
10/15/2003EP1351690A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
10/15/2003CN1448390A Method of extracting Shishanjianjia from Chinese herbal medicine multi-layer tower
10/15/2003CN1124265C Method for producing aromatic bisimides
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003CA2479930A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/08/2003EP1214318B1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
10/08/2003CN1447792A Aporphine esters and their use in therapy
10/07/2003US6630483 Phenanthridine-N-oxides
10/07/2003US6630472 Compounds, pharmaceutical compositions, and methods for stimulating neuronal growth and elongation
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003US20030187147 Reacting a iminoester with polymer
10/02/2003US20030187012 Reduction physical cigarette smoking
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030186901 Method of inhibiting neurotrophin-receptor binding
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2480384A1 Phenanthridinones as parp inhibitors
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
09/2003
09/30/2003US6627640 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
09/30/2003US6627638 Viricides, anticarcinogneic agents
09/25/2003WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
09/25/2003WO2003013530A3 Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid derivatives as nmda antagonists
09/25/2003WO2002036573B1 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
09/25/2003US20030181458 Preferential serotonin receptors antagonists comprising heterocyclic amines used for prophylaxis or prevention of headaches, sleep, sexual or eating disorders and as antidepressants
09/24/2003EP1345889A1 Method for the regioselective preparation of substituted benzo g]quinoline-3-carbonitriles and benzo g]quinazolines
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1100802B1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF
09/23/2003CA2072814C Benzomorphans and their use as pharmaceutical compositions
09/18/2003WO2003076417A2 Oxo-azabicyclic compounds
09/18/2003WO2003076416A1 Oxo azabicyclic compounds
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176464 Phenyl substituted 4-hydroxy tetrahydroxypyridone
09/18/2003US20030176451 Reacting a heterocyclic-methanesulfonyl substituted-quinazolineamine compound with amine compound
09/18/2003CA2478706A1 Oxo-azabicyclic compounds
09/17/2003EP1343840A1 Preparation of dyed plastics or polymeric dye particles
09/17/2003EP1343768A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
09/17/2003EP0984777B1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
09/17/2003EP0910560B1 Process for preparing 2-aryl-substituted indenes
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620821 HMG-CoA reductase inhibitors and method
09/16/2003CA2283671C Salt of naphthyridine carboxylic acid derivative
09/16/2003CA2046429C Imide derivatives, and their production and use
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171390 Modulators of Rho C activity
09/11/2003US20030171373 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1341793A2 Crf receptor antagonists and methods relating thereto
09/10/2003EP1341769A2 Bacterial gyrase inhibitors and uses thereof
09/10/2003EP1341536A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
09/10/2003EP0984942B1 Liquid benz-iso-quinoline derivatives
09/10/2003CN1441805A Antitumoral analogue of Et-743
09/04/2003WO2003072549A1 Farnesyl protein transferase inhibitors as antitumor agents
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003CA2477328A1 Pyridyl tricyclic compounds as farnesyl protein transferase inhibitors and antitumor agents
09/03/2003EP1341403A1 Luminescent element material and luminescent element comprising the same
09/03/2003EP1339798A2 Sulfonated diarylrhodamine dyes
09/03/2003EP1339689A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1070065B1 Azabicyclic 5ht1 receptor ligands
09/03/2003EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/03/2003CN1440414A Synthesis of cuttlefish compound
09/02/2003US6613904 Process for production of gabapentin intermediate
08/2003
08/28/2003WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070245A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003US20030162804 Tertiary amines such as N-allyloxyethyl-1,2,3,4,5,6-hexahydro -6,11,11-trimethyl-2,6- methano-3-benzazocin-10-ol and salts, administered as sodium channel modulators for prophylaxis of arrhythmias, spasms or epilepsy
08/28/2003CA2476115A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/27/2003EP1337506A1 Improved process for production of gabapentin intermediate
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 110